1.No association of prion protein gene polymorphisms with Alzheimer's disease in Korean population.
Kyungsook AHN ; Eunkyung KIM ; Young A KWON ; Doh Kwan KIM ; Jong Eun LEE ; Sangmee Ahn JO
Experimental & Molecular Medicine 2006;38(6):727-731
The polymorphism at codon 129 (M129V) of the human prion protein gene (PRNP) is a known risk factor for Creutzfeldt-Jakob disease (CJD) in Caucasians. There are few reports of this polymorphism's effect on memory and on the risk of Alzheimer's disease (AD). The M129V genotype distributions among Asians are very different from Caucasians. Another polymorphism, codon 219 (E219K) is not found in Caucasians. We investigated two polymorphisms of PRNP, M129V (rs1799990) and E219K (rs1800014) in 297 Korean AD patients and 217 healthy subjects. The analysis of the genotype and allele distributions showed no significant difference between the AD patients and the controls in both polymorphisms (P=0.19 genotype, P=0.51 allele for M129V; P=0.64 genotype, P=0.50 allele for E219K). Also, the PRNP polymorphisms were not significantly associated with AD when the populations were stratified for the presence or absence of apolipoprotein E-e4 (ApoE-epsilon4) allele. These results suggest that the PRNP genetic variants are not associated with the risk for AD in Korean population.
Prions/*genetics
;
Polymorphism, Genetic/*genetics
;
Male
;
Korea/epidemiology
;
Humans
;
Genotype
;
Genetic Predisposition to Disease/genetics
;
Female
;
Codon/genetics
;
Apolipoproteins E/genetics
;
Alzheimer Disease/*epidemiology/*genetics
;
Alleles
;
Aged
2.Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD).
Toshiharu NINOMIYA ; Shigeyuki NAKAJI ; Tetsuya MAEDA ; Masahito YAMADA ; Masaru MIMURA ; Kenji NAKASHIMA ; Takaaki MORI ; Minoru TAKEBAYASHI ; Tomoyuki OHARA ; Jun HATA ; Yoshihiro KOKUBO ; Kazuhiro UCHIDA ; Yasuyuki TAKI ; Shuzo KUMAGAI ; Koji YONEMOTO ; Hisako YOSHIDA ; Kaori MUTO ; Yukihide MOMOZAWA ; Masato AKIYAMA ; Michiaki KUBO ; Manabu IKEDA ; Shigenobu KANBA ; Yutaka KIYOHARA
Environmental Health and Preventive Medicine 2020;25(1):64-64
BACKGROUND:
The burden of dementia is growing rapidly and has become a medical and social problem in Japan. Prospective cohort studies have been considered an effective methodology to clarify the risk factors and the etiology of dementia. We aimed to perform a large-scale dementia cohort study to elucidate environmental and genetic risk factors for dementia, as well as their interaction.
METHODS:
The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) is a multisite, population-based prospective cohort study of dementia, which was designed to enroll approximately 10,000 community-dwelling residents aged 65 years or older from 8 sites in Japan and to follow them up prospectively for at least 5 years. Baseline exposure data, including lifestyles, medical information, diets, physical activities, blood pressure, cognitive function, blood test, brain magnetic resonance imaging (MRI), and DNA samples, were collected with a pre-specified protocol and standardized measurement methods. The primary outcome was the development of dementia and its subtypes. The diagnosis of dementia was adjudicated by an endpoint adjudication committee using standard criteria and clinical information according to the Diagnostic and Statistical Manual of Mental Disorders, 3rd Revised Edition. For brain MRI, three-dimensional acquisition of T1-weighted images was performed. Individual participant data were pooled for data analyses.
RESULTS:
The baseline survey was conducted from 2016 to 2018. The follow-up surveys are ongoing. A total of 11,410 individuals aged 65 years or older participated in the study. The mean age was 74.4 years, and 41.9% were male. The prevalence of dementia at baseline was 8.5% in overall participants. However, it was 16.4% among three sites where additional home visit and/or nursing home visit surveys were performed. Approximately two-thirds of dementia cases at baseline were Alzheimer's disease.
CONCLUSIONS
The prospective cohort data from the JPSC-AD will provide valuable insights regarding the risk factors and etiology of dementia as well as for the development of predictive models and diagnostic markers for the future onset of dementia. The findings of this study will improve our understanding of dementia and provide helpful information to establish effective preventive strategies for dementia in Japan.
Aged
;
Alzheimer Disease/genetics*
;
Dementia/genetics*
;
Environment
;
Female
;
Humans
;
Incidence
;
Japan/epidemiology*
;
Male
;
Middle Aged
;
Prevalence
;
Prospective Studies
;
Risk Factors
3.Alzheimer's disease: epidemiology, genetics, and beyond.
Xiao-Ping WANG ; Hong-Liu DING
Neuroscience Bulletin 2008;24(2):105-109
Alzheimer's disease (AD) is an increasing epidemic threatening public health. Both men and women are susceptible to the disease although women are at a slightly higher risk. The prevalence of AD rises exponentially in elderly people from 1% at age of 65 to approximately 40%-50% by the age of 95. While the cause of the disease has not been fully understood, genetics plays a role in the onset of the disease. Mutations in three genes (APP, PSEN1, and PSEN2) have been found to cause AD and APOE4 allele increases the risk of the disease. As human genomic research progresses, more genes have been identified and linked with AD. Genetic screening tests for persons at high risk of AD are currently available and may help them as well as their families better prepare for a later life with AD.
Aged
;
Aged, 80 and over
;
Aging
;
genetics
;
metabolism
;
Alzheimer Disease
;
diagnosis
;
epidemiology
;
genetics
;
Amyloid beta-Protein Precursor
;
genetics
;
metabolism
;
Apolipoprotein E4
;
genetics
;
Genetic Predisposition to Disease
;
genetics
;
Genetic Testing
;
trends
;
Humans
;
Mutation
;
genetics
;
Presenilins
;
genetics
;
metabolism
;
Risk Factors